Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -347.29x is 53% above its 3-year average of -743.64x, near the high end of its 3-year range (-5532.43x–-0.67x).
80.52% above its 12-month average of -1782.75x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -58.69x.
INTEREST COVERAGE RATIO
-347.29x
INTEREST COVERAGE RATIO AVG TTM
-1782.75x
INTEREST COVERAGE RATIO AVG 3Y
-828.07x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+80.52%
CURRENT VS 3Y AVG
+58.06%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
-5898.10%
vs the sector median at left
Kyverna Therapeutics, Inc.
Market Cap
$383.01M
Interest Coverage Ratio
-347.29x
TTM Avg
-1782.75x
3Y Avg
-828.07x
5Y Avg
N/A
Market Cap
$383.91M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$386.46M
Interest Coverage Ratio
-3.92x
TTM Avg
67.22x
3Y Avg
51.13x
5Y Avg
40.74x
Market Cap
$380.89M
Interest Coverage Ratio
N/A
TTM Avg
4.06x
3Y Avg
4.06x
5Y Avg
4.06x
Market Cap
$390.34M
Interest Coverage Ratio
-3.58x
TTM Avg
6.09x
3Y Avg
6.09x
5Y Avg
6.09x
Market Cap
$373.99M
Interest Coverage Ratio
-1.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$396.42M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$362.81M
Interest Coverage Ratio
-12.13x
TTM Avg
372.18x
3Y Avg
320.22x
5Y Avg
320.22x
Market Cap
$362.76M
Interest Coverage Ratio
-26.33x
TTM Avg
2025.11x
3Y Avg
2025.11x
5Y Avg
2025.11x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | $383.01M | -347.29x | -1782.75x | -828.07x | N/A |
| YD Bio Limited Ordinary Shares (YDES)vs › | $383.91M | N/A | N/A | N/A | N/A |
| Orthofix Medical Inc. (OFIX)vs › | $386.46M | -3.92x | 67.22x | 51.13x | 40.74x |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $380.89M | N/A | 4.06x | 4.06x | 4.06x |
| REGENXBIO Inc. (RGNX)vs › | $390.34M | -3.58x | 6.09x | 6.09x | 6.09x |
| Canopy Growth Corporation (CGC)vs › | $373.99M | -1.91x | N/A | N/A | N/A |
| MapLight Therapeutics, Inc. (MPLT)vs › | $396.42M | N/A | N/A | N/A | N/A |
| Ocugen, Inc. (OCGN)vs › | $362.81M | -12.13x | 372.18x | 320.22x | 320.22x |
| Opus Genetics, Inc. (IRD)vs › | $362.76M | -26.33x | 2025.11x | 2025.11x | 2025.11x |
| Carlsmed, Inc. (CARL)vs › | $405.33M | -21.38x | N/A | N/A | N/A |
Interest Coverage
-347.3x
Debt/Equity
0.20
Current Ratio
9.06
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -58.69x |
| 2026-03-31 | -62.02x |
| 2025-12-31 | -88.47x |
| 2025-09-30 | -5532.43x |
| 2025-06-30 | -3172.14x |
| 2025-03-31 | -1896.32x |
| 2024-12-31 | -1520.04x |
| 2024-09-30 | -1211.56x |
| 2024-06-30 | -857.31x |
| 2024-03-31 | -0.67x |
| 2023-12-31 | -454.83x |
| 2023-09-30 | -325.64x |
| 2023-06-30 | -289.17x |
| 2023-03-31 | -260.11x |
| 2022-12-31 | -214.02x |
